The use of combinatorial libraries for the identifi cation of novel opiate and related ligands in opioid receptor assays is reviewed. Case studies involving opioid assays used to demonstrate the viability of combinatorial libraries are described. The identifi cation of new opioid peptides composed of L-amino acids, D-amino acids, or L-, D-, and unnatural amino acids is reviewed. New opioid compounds have also been identifi ed from peptidomimetic libraries, such as peptoids and alkylated dipeptides, and those identifi ed from acyclic (eg, polyamine, urea) and heterocyclic (eg, bicyclic guanidine) libraries are reviewed.
INTRODUCTION
Binding to opioid receptors was fi rst demonstrated in 1973 [1] [2] [3] ; the endogenous peptides were fi rst discovered in 1975. 4 Since then, the search for new opioid ligands with better selectivity has continued. The search for the " holy grail " of opiates -that is, an opiate ligand without the traditional side effects (addiction, tolerance, respiratory depression, etc) -is ongoing, though with diminished expectations. Thousands of analogs of the natural opioid peptides enkephalin, dynorphin, endorphin, dermenkephalin, and dermorphin have been synthesized over the past 20 years and used to determine the workings of the opioid receptor family. More recently, highly selective compounds (in most cases structurally related to the classic opiates, eg, morphine) have been identifi ed and used as research tools. Why then would one want to identify additional compounds that interact with opioid receptors? First, the question of the existence, number, and nature of subtypes of the 3 receptors remains unanswered. Two subtypes have been proposed for the mu receptor ( 1 , 2 ); delta receptor subtypes have been classifi ed by 2 different schools of thought, into ␦ 1 and ␦ 2 by one school and ␦ cx and ␦ ncx by another; and subtypes reported for the kappa receptor include 1 , 2 , 3 , 1a , 1b , 2a , and 2b . 5 To date, only a single gene has been identifi ed for each of the 3 opioid receptors, mu, 6 , 7 delta, 8 , 9 and kappa. 10 While alternate splicing and posttranslational modifi cations may prove to be responsible for receptor subtype expression, they have yet to be verifi ed with pharmacological data. New ligands specifi c for, rather than selective for, the receptor subtypes would greatly facilitate binding studies. Structurally distinct new ligands may cover the binding spectrum of a particular receptor more completely and indicate whether ligands are binding to slightly different positions on the same receptor, thus giving rise to different inhibition profi les. The inability to determine specifi c ligands for the receptor subtypes may indicate that the differences observed in vivo are due to postbinding events (signaling). Second, new ligands may prove more useful as tools for in vivo study. Structurally diverse ligands will aid in the study of analgesic effi cacy, addiction, and tolerance and will delineate central and peripheral antinociception, thus leading to effective new analgesics or treatments for drug abuse.
This review covers the use of combinatorial libraries in opioid binding assays, from an early demonstration of the concept to recently identifi ed peptide and nonpeptide ligands. In our own research we have used combinatorial libraries to study opioids and, conversely, have used opioid receptors to study combinatorial libraries. This approach has demonstrated that mixture-based libraries can be used with a wide range of compound classes. It has also led to the development of a more rapid means of deconvolution for the identifi cation of a wide variety of new ligands for the opioid receptors, and as fi rst reported herein, a proof of concept illustration of its direct use in selected in vivo assays for the identifi cation of inherently more advanced " hits " than those identifi ed via traditional target-based in vitro assays.
SYNTHETIC COMBINATORIAL LIBRARIES
Synthetic combinatorial libraries were originally described for peptides but are now used with a wide variety of compound types; such libraries are responsible for the remarkable transformation of the manner in which new therapeutics and diagnostics are identifi ed. The term combinatorial was E372 originally applied to describe collections of compounds containing all possible combinations of the building blocks used in their preparation. " Combinatorial library " is a term now more generally used to describe collections of compounds ranging in number from a few dozen to more than 10 12 . The fi rst libraries described truly were combinatorial, since they represented a complete set of the compounds possible with the building blocks used and were generated either biologically (using molecular biology techniques) or synthetically. In the former, the peptide or protein diversity was presented on the surface of fi lamentous phage particles or plasmids. [11] [12] [13] In the latter, synthetic chemistry was used to generate a diversity of peptides attached to a solid support. The fi rst synthetic combinatorial library described in the literature was composed of mixtures of tens to hundreds of thousands of octapeptides on plastic pins. 14 This was followed by 2 simultaneous reports in 1991, the fi rst of which described a second immobilized method, referred to as the one bead/one peptide approach. 15 Immobilized libraries can be assayed for binding to soluble receptors (eg, antibodies). However, the vast majority of receptors are membranebound and cannot be readily screened with libraries attached to a support. Chemical synthesis of libraries on a solid support, which are subsequently cleaved and screened in solution, allows for a wider range of assays to be screened. This approach was fi rst presented in the second of the 2 reports from 1991. 16 , 17 The ability to screen mixtures that are free in solution confers decided advantages, in that a broad spectrum of assays can be used without alteration, and the concentration of the library mixtures being screened can be varied to adjust to the needs of the particular assay.
There remain 2 schools of thought regarding the screening of combinatorial libraries: (1) screen the greatest diversity possible, primarily through the use of mixtures, or (2) screen smaller diversities, primarily through the use of parallel arrays in conjunction with high-throughput screening. Although the successful use of mixture-based libraries was presented more than a decade ago, until recently the trend in the pharmaceutical industry has been to synthesize libraries as large parallel arrays of individual compounds, which are then screened individually or in small pools. Studies performed by our own and other laboratories, however, have shown that mixture-based libraries are a rapid, costeffective means for the identifi cation of extremely active, highly specifi c individual compounds. 18 Combinatorial libraries are synthesized using solid-phase chemistry involving the consecutive incorporation of multifunctional building blocks with orthogonal protecting groups 19 , 20 and contain a varied number of diversity positions. The solid support is typically polystyrene, but libraries have also been synthesized on plastic pins 14 paper, 21 cotton, 22 and silicon chips. 23 Since amide bond formation on the solid phase has been optimized through 30 years of solid-phase peptide synthesis, it has been used extensively in combinatorial synthesis.
One of 2 methods is used to generate the approximate equimolarity required for mixture-based libraries. In the fi rst, equimolarity is achieved by mixing precoupled resins (a process termed divide-couple-recombine, 16 split synthesis, 15 or portioning-mixing 24 ). In the second, mixtures of incoming reagents are used during coupling. 25 The latter method also enables incorporation of mixture positions after the defi ned position has been incorporated, which is critical for most positional scanning libraries.
The initial combinatorial libraries described were all peptide libraries. Because of well-developed synthetic methods, amino acids and short peptides can be used as starting materials for the synthesis of low-molecular-weight heterocyclic libraries. The ability to exhaustively transform whole libraries of compounds to libraries of entirely different pharmacophores has been developed in our laboratory. [26] [27] [28] [29] [30] [31] With this approach (termed libraries from libraries), the original diversity in a library may be expanded via chemical modifi cation of the entire library. For example, peptide libraries may be modifi ed by exhaustive methylation of their amide bonds to yield peptidomimetics, 31 by complete reduction of the backbone amide carbonyl groups to yield polyamines, 32 or by a combination of both to obtain alkylated polyamines.
Unlike parallel array libraries, mixture-based libraries must be deconvoluted to identify active compounds. While several mixture deconvolution methods have been described, including direct sequencing, encoded tags, highperformance liquid chromatography, mass spectrometry, and orthogonal synthesis, they have not been applied to the identifi cation of opioid ligands and thus will not be discussed further in this review. The 2 most widely used de convolution strategies for soluble combinatorial libraries are iterative 16 , 17 and positional scanning. 33 , 34 The iterative deconvolution approach uses a step-by-step selection and enhancement process to identify individual compounds. The most active sequence in this process is thus identifi ed by the systematic reduction in the number of compounds in the most active mixture. The positional scanning deconvolution approach is a more rapid means to gather information about all possible variable positions in a soluble mixture library and was fi rst presented by our laboratory in 1992. 33 As an illustration of the method for a simple tetrapeptide combinatorial library, envision 4 different amino acids (D, F, I, N) incorporated at each of 4 different variable positions, resulting in 256 (4 4 ) ) . In this example, assume that the sequence FIND-NH 2 is the sole tetrapeptide having activity, with the other 255 being completely inactive. Since each positional sublibrary contains all 256 peptides, the individual tetrapeptide is present in only 1 mixture in each of the 4 positional sublibraries. Thus, the mixtures having activity will be FXXX-NH 2 , XIXX-NH 2 , XXNX-NH 2 , and XXXD-NH 2 because of activity of FIND-NH 2 . These 4 amino acids in their respective positions yield the sequence FIND in the initial screening. The corresponding peptide is then synthesized and tested for activity. It should be noted that the activity observed for each of the 4 mixtures is due to the presence of the tetrapeptide FIND-NH 2 in each mixture and is not due to the individual amino acids (F, I, N, and D) that occupy the defi ned positions. Often, more than 1 mixture is found to have activity at each position. Building block selection for the synthesis of individual compounds is based fi rst on the activity of the mixture, but if there are too many possibilities, then similarities in chemical character may be used to reduce the number of individual compounds to be made. Freier and coworkers have provided an excellent discussion of the theoretical and experimental aspects of iterative and positional scanning deconvolution. 35 , 36 
IDENTIFICATION OF OPIOID LIGANDS: CASE STUDIES USING COMBINATORIAL LIBRARIES
The monoclonal antibody (mAb) 3E7 raised against ␤ -endorphin was used in many of the fi rst screens of combinatorial libraries as a receptor of convenience. The antigenic determinant recognized by this antibody is well understood and represents the 6 residues of the N-terminal of ␤ -endorphin, YGGFMT. This antibody is also known to bind to a variety of other related endogenous opioid ligands having similar N-terminal residues. This antigen/antibody system proved to be a good model for the early testing of library feasibility. 37 mAb 3E7 was fi rst used in conjunction with the molecular biology approach, in which a library of peptide sequences was expressed on the N terminus of pIII, a fusion protein. 11 When a process of affi nity purifi cation termed biopanning was used, the enkephalin sequences YGGFM and YGGFL were not initially found, but peptides that bound with high affi nity to mAb 3E7 (YGAFMQ, 13 nM) were reported. Using a related approach with mAb 3E7, McLafferty et al 38 tested a phage display library. Five of the 6 clones derived from the library contained sequences related to YGGF boarded by cysteine residues. mAb 3E7 was also used to demonstrate the principle of an approach in which thousands of individual peptides were synthesized on the silica surfaces of microchips using light-directed synthesis. 23 In this study, 1024 individual peptides were synthesized and screened to determine their binding to mAb 3E7. Active sequences (15 peptides) were found after visualization using a fl uorescein-labeled antibody. The one bead/one peptide approach 15 was also examined using mAb 3E7, in which binding was monitored by an alkaline phosphatase assay to produce a blue color in active beads. Specifi c peptides were identifi ed by Edman degradation microsequencing. Six sequences were identifi ed, the most active of which was found to be YGGFQ (K i = 15 nM). Kassarjian et al 39 used a similar process with I 125 -labeled anti-␤ -endorphin mAb 3E7. Salmon et al 40 used an improved version of this approach, in which small quantities of peptide were released into and tested in solution. mAb 3E7 was again employed to verify the use of this library approach -3 peptide sequences were identifi ed, 1 of which corresponded with the fi rst 4 positions of methionine-and leucineenkephalin. Although screening membrane-bound receptors is now possible, one bead/one peptide libraries have not been screened in membrane-bound opioid receptor assays.
Use of libraries with membrane-bound receptors has so far been limited to those that can be screened with compounds free in solution. Such a library was used in a case study our laboratory performed employing a opioid receptor binding assay and a hexapeptide synthetic combinatorial library composed of 400 different mixtures, each of which contained an equimolar mixture of 130 321 hexapeptides, for a library total of 52 128 400 L-amino acid hexapeptides. Two of the 6 positions were specifi cally defi ned using 20 naturally occurring L-amino acids (O); the remaining 4 positions were made up of mixtures of 19 amino acids (X; cysteine excluded). In the initial screening all 400 mixtures were tested at a single concentration for their ability to inhibit binding of tritiated DAMGO. IC 50 values were subsequently determined for the most effective peptide mixtures. YGXXXX-NH 2 was found to be the most effective inhibiting mixture. An iterative process was performed in which the subsequent X positions of YGXXXX-NH 2 were successively defi ned. For each of the 4 iterations, 20 peptide mixtures were synthesized. The fi nal deconvolution yielded sequences in which the fi rst 5 residues corresponded to the naturally occurring opioid peptide sequences of methionine and leucine enkephalin (YGGFMA-NH 2 IC 50 = 28 nM and YGGFLG-NH 2 IC 50 = 59 nM 41 ).
Positional scanning deconvolution was also demonstrated using the mu opioid receptor binding assay as a case study. 34 A hexapeptide PS-SCL consisting of 6 separate sublibraries, each having a single position defi ned with the remaining 5 positions as mixtures (O 1 XXXXX-NH 2 , XO 2 XXXX-NH 2 , XXO 3 XXX-NH 2 , XXXO 4 XX-NH 2 , XXXXO 5 X-NH 2 , and XXXXXO 6 -NH 2 ; 108 separate peptide mixtures), was screened. Each mixture was composed of ~18 5 
IDENTIFICATION OF NOVEL OPIOID PEPTIDES

L-Amino Acid Libraries
Screening of an N-acetylated library, Ac-OOXXXX-NH 2 , in a binding assay yielded new opioid antagonists with no homology to known opioid peptides. 42 , 43 The individual peptides derived from this library have been termed acetalins. Three peptides, Ac-RFMWMR-NH 2 , Ac-RFMWMK-NH 2 , and Ac-RFMWMT-NH 2 , were tested for their selectivity among opioid receptors in , ␦ , 1 , 2 , and 3 receptor binding assays. These peptides showed high affi nity for and 3 opioid receptors, somewhat lower affi nity for ␦ receptors, weak affi nity for 1 receptors, and no affi nity for 2 receptors. They were found to be potent receptor antagonists in the guinea pig ileum assay and relatively weak antagonists in the mouse vas deferens assay. These peptides represent a new class of opioid receptor ligands. This study exemplifi es the power of mixture-based combinatorial libraries for the identifi cation of new ligands; such ligands would not have been found using classical structure-activity relationship (SAR) techniques.
Iterations were completed for additional mixtures found to have activity in the initial screening of the nonacetylated and acetylated hexapeptide libraries OOXXXX-NH 2 and Ac-OOXXXX-NH 2 . 44 Two new series of nonacetylated hexapeptides not related to the enkephalins were identifi ed, YPFGFO-NH 2 and WWPKHO-NH 2 (where O = 1 of 20 L-amino acids). Both possessed high affi nity (IC 50 values of the most active peptides were 10-15 nM) and selectivity for the receptor, individuals of which were found to be agonists. Two additional series were identifi ed from the acetylated library, Ac-FRWWYO-NH 2 and Ac-RWIGWO-NH 2 (IC 50 values of the most active peptides were 5-10 nM). The peptide Ac-FRWWYM-NH 2 was determined to be an agonist for the receptor, whereas the peptide Ac-RWIGWR-NH 2 was found to be an antagonist at this receptor. In total, 6 different families of sequences were identifi ed from the 2 libraries ( Table 1 ) .
A positional scanning format of the hexapeptide library, in which 2 positions are defi ned for each sublibrary, was used to identify ligands for the delta receptor. The 3 related L-amino acid sublibraries (composed of identical hexapeptides but differing in the location of their defi ned positions, OOXXXX-NH 2 , XXOOXX-NH 2 , and XXXXOO-NH 2 ) were used to identify a new ligand for the delta receptor, YGFDLV-NH 2 (IC 50 =15 nM). This peptide is similar to the sequences found when a single-position-defi ned positional scanning library was used in an earlier study, YHGWLV-NH 2 and YGMHLV-NH 2 . 47 YGFDLV-NH 2 was found to be an agonist at the delta receptor. Burgess et al synthesized a library made up of a total of 96 peptides based on the sequences YGGFL-NH 2 and YGGFLRF-NH 2 to explore the effects of incorporating 2,3 methanoamino acids, in particular stereoisomers of 2,3 methanoleucine. 52 None of the compounds, however, were found to show improved activity over the native peptides. The authors concluded that binding in mu and delta receptors is governed by amino acids other than the leu 5 residue.
D-Amino Acid Libraries
A mixture-based combinatorial library containing all D-amino acid hexapeptides (Ac-ooxxxx-NH 2 ) was used to identify a novel ligand for the opioid receptor, Ac-rfwink-NH 2 (IC 50 = 18 nM). 49 While the fi rst 2 amino acid side chains (Arg and Phe) and the presence of the N-terminal acetyl is similar to that found in the acetalins, the D form of the amino acids was found to be essential. The systematic replacement of each of the 6 positions with each of the 20 L-amino acids yielded inactive peptides. The all-D-amino acid peptide exhibits high selectivity for receptors (K i values: 1 = 16 ± 0.5 nM, 2 = 41 ± 4.8 nM). Ac-rfwink-NH 2 had a K i value of greater than 1500 nM for delta receptors, had very low affi nity in assays for the 1 (K i > 2000 nM) and 2 (K i > 5000 nM) receptor subtypes, and had only modest affi nity in assays for 3 receptors (K i = 288 ± 71 nM). Ac-rfwink-NH 2 was shown to be a full agonist in the guinea pig ileum assay (EC 50 = 433 ± 43 nM). This activity was antagonized by naloxone at a low concentration (K e = 3.80 nM), indicating that it was an opioid effect mediated through interaction with opioid receptors. Ac-rfwink-NH 2 is a potent agonist at the receptor and induces long-lasting analgesia in mice. The in vivo potency of Ac-rfwink-NH 2 (ED 50 = 0.6 nmol, intracerebroventricular) was found to be approximately twice that obtained for morphine (ED 50 = 1.29 nmol, icv). Ac-rfwink-NH 2 produced antinociception equal to that of morphine following intraperitoneal (ip) administration. Since analgesia produced by ip-administered Ac-rfwink-NH 2 is blocked by icv administration of naloxone, this peptide is most likely able to cross the blood-brain barrier.
A nonacetylated library made up entirely of D-amino acid hexapeptides (ooxxxx-NH 2 ) was also found to have activity at the mu receptor. Four iterative syntheses (20 mixtures for each iteration) were performed on each of the 2 mixtures found to be most active: imxxxx-NH 2 and itxxxx-NH 2 .
Upon completion of the iterative deconvolution process, the 2 peptides found to bind with the highest affi nity to the mu receptor were iftwyr-NH 2 (IC 50 = 5 nM) and imswwg-NH 2 (IC 50 = 10 nM) ( Table 1 ). These peptides are yet another class of opioid peptide, in that they do not have the typical N-terminal free tyrosine of endogenous ligands or the N-terminal arginine of the acetalins or Ac-rfwink-NH 2 .
Mixed L-and D-Amino Acid Libraries
A synthetic peptide combinatorial library composed of mixtures of 50 different L-, D-, and unnatural amino acids (OXXX-NH 2 ) was screened in the 3 opioid binding assays.
The tetrapeptide library contained 6.5 million peptides and required iterative deconvolution. Iterations were completed for the most active mixture at the mu receptor. After 3 iterative syntheses (50 mixtures each), the most active individual peptide found was YmFA-NH 2 (IC 50 = 2 nM). This compound was found to be a highly mu-specifi c receptor agonist. 45 A tetrapeptide positional scanning library that differed slightly in the amino acid making up the library was also synthesized and screened. Following an extensive study, 46 individual compounds were identifi ed for all 3 opioid receptors, mu, delta, and kappa. The most active peptide for the mu receptor was Y(D-Nve-)G(L-Nal)-NH 2 (K i = 0.4 nM), while the most mu-selective peptide found was YrAW-NH 2 , with : ␦ and : ratios of greater than 1000 ( Table 1 ) . The most selective peptide identifi ed for the delta receptor was Wy(aAba)R-NH 2 (K i = 7 nM). The most active peptide identifi ed for the kappa receptor was ff(D-Nle)r-NH 2 (K i = 1 nM). The tetrapeptides identifi ed for the kappa receptor were highly selective for this receptor, with : and : ␦ ratios of greater than 10 000. 46 The kappa-selective peptide kaffi ralin (ffi r-NH 2 ) is a full agonist in the GTP ␥ S binding assay (EC 50 = 10 nM hKOR-CHO cells). Kaffi ralin generated a full dose-response curve in the mouse 55°C warm water tail fl ick assay and in the acetic acid writhing test after icv administration. It was ~10-fold more potent in the writhing test than in the tail fl ick test. After ip administration, kaffi ralin did not produce a full dose-response curve in the tail fl ick assay, but it did in the writhing test. It was antagonized by an ip injection of nor-binaltorphimine (nor-BNI) but not an icv injection of nor-BNI. When given by ip administration, ffi r-NH 2 may produce antinociception at spinal or peripheral receptors instead of supraspinal receptors. There was no evidence of the peptide crossing the blood-brain barrier (J. Bidlack and B. Urban, oral communication, 1999).
Fluorescent-Labeled Libraries
In a recent study, kappa-selective peptides having intrinsic fl uorescent properties were identifi ed from a rhodaminelabeled tetrapeptide PS-SCL. 50 From a library of ~7.3 million rhodamine-labeled tetrapeptides, more than 250 individual peptides were synthesized from the most active mixtures. Eight individual rhodamine-labeled peptides were identifi ed that were specifi c for the kappa opioid receptor, having binding affi nities ranging from 5 to 20 nM ( Table 1 ). The majority of the most active peptides identifi ed contained at least 2 positively charged residues. Such strongly positively charged compounds have the potential for nonspecifi c binding to the receptor through ionic interactions. This was found not to be the case since the same peptides lacking a rhodamine label did not inhibit binding of the radioligand to the kappa receptor (K i >10 M). As rhodamine and rhodamine sulfonyl amide had no inhibitory activity, the peptide sequence together with the rhodamine moiety were necessary components of a single molecule responsible for receptor binding. We are currently pursuing a range of other fl uorescent groups in a similar manner with both peptide and nonpeptide libraries for the identifi cation of opioid receptor -specifi c ligands.
Orphanin FQ/Nociceptin
In October and November 1995, 2 separate reports were published 57 , 58 on the identifi cation of the endogenous ligand for the orphan receptor ORL1, a potential member of the opioid family of receptors. After establishing a binding assay in rat brain using tritiated orphanin FQ, 48 a hexapeptide positional scanning library containing 2 defi ned positions (1200 mixtures) was used to identify hexapeptide ligands for this receptor. The most active peptide found was Ac-RYYRWK-NH 2 . The 5 most active compounds were found to be agonists using 3 separate biochemical bioassays: inhibition of cyclic adenosine monophosphate (cAMP) accumulation, stimulation of [ 35 S]GTP ␥ S binding, and inhibition of electrically induced contractions in the mouse vas deferens. 59 
Peptidomimetic Libraries
The fi rst use of a peptidomimetic library for the identifi cation of opioids was described by Zuckermann et al, 51 who screened a library of 5000 peptoids (oligo-N-substituted glycines). The library, composed of 3 sets of monomers (22 different monomers) from commercially available amines, and with the amino terminus either as a free amine, N-acetylated or capped with cyclohexylurea, contained 204 peptoid trimers in 18 different mixtures. This library was screened in a -specifi c radioreceptor assay with 3 H-DAMGO as the radioligand. Through use of an iterative process in which the most active mixture from the fi rst screening was deconvoluted by individually defi ning the fi rst, second, and third positions in sequential order, 3 highly active compounds were found. The most active compound, CHIR 4531, had a K i value of 6 nM.
A dipeptidomimetic library based on a dipeptide scaffold with the C-terminal and middle amide hydrogens replaced separately with 5 different alkyl groups (methyl, ethyl, allyl, benzyl, or naphthylmethyl) was also used to identify opioid ligands. 53 The 2 variable amino acid positions of this library were made up of 50 different L-, D-, and nonproteinogenic amino acids. The library, which contained 57 500 different compounds and was screened against all 3 opioid receptors, required 2 iterative syntheses to identify individual compounds. Highly active individual compounds were identifi ed for each of the 3 receptors: mu (TPI 418-1 K i = 6 nM), delta (TPI 452-19 K i = 39 nM), and kappa (TPI 419-19 K i = 1 nM) ( Figure 1 ). All 3 were found to be agonists at their particular receptors. The selectivity of the mu and kappa compounds was high, while that of the delta ligand was poor, with the compound binding equally to kappa receptors. 
Nonpeptide Libraries
In contrast to the stepwise synthesis of peptidomimetics mentioned above, the transformation of peptide libraries to libraries of entirely different pharmacophores has been reported. 31 The approach, termed libraries from libraries, extends the diversity obtained with peptide libraries via chemical modifi cation. Peptide libraries have been successfully modifi ed by exhaustive methylation of their amide bonds to yield peptidomimetics 31 and/or by reduction of the backbone amide carbonyl groups to yield polyamines. 32 A chemically modifi ed peptide library in which all of the peptide amide carbonyls were reduced to methylenes was screened for opioid ligands. Mu-selective opioid compounds were identifi ed from a library made up of 52 million different heptamines. 54 The Figure  1 ), which was found to be a highly specifi c, pure antagonist at the mu receptor. It was also found to be much less toxic than the unmodifi ed pentamine from which it was derived. This example illustrates how compounds may be further refi ned after initial identifi cation from a library.
A bicyclic guanidine library containing more than 100 000 different heterocyclic compounds was screened in the opiate assays. Twenty-four (3 × 4 × 2) individual bicyclic guanidines were then synthesized and tested for activity; they were found to range from 37 to 10 000 nM. The most active compound found was TPI 614-1 (IC 50 = 37 nM, Figure 1 ).
Even when libraries are not derived from peptide precursors, diversity in many libraries is achieved through the use of amino acid side chains. A library of over 125 000 linear N,N ' -di-substituted ureas was used to identify ligands for mu and sigma receptors. The 276 separate mixtures in this library were each made up of 452 different linear ureas. Two separate iterative deconvolutions were performed for the most active mixtures found for the mu and sigma receptors. The most active compound found for the mu receptor was TPI 632-4 (IC 50 = 100 nM). Two active compounds were identifi ed having activity at the sigma receptor, TPI 634-6 (IC 50 = 5 nM) and TPI 632-9 (IC 50 = 30 nM). 28 Similarly, individual compounds were identifi ed for the sigma receptor from a dialkylated hydantoin library. The 2 most active compounds found were TPI 610-2 (IC 50 = 62 nM) and TPI 610-4 (IC 50 = 64 nM). 29 A library of 43 472 isoquinolines was also used to identify new sigma receptor ligands. The most active compound identifi ed from this library was TPI 462-4 (IC 50 = 56 nM). 55 A parallel synthetic strategy of 288 compounds was used by Thomas et al to identify kappa antagonists. The library was designed around N-substituted (+)-(3R,4R)-dimethyl-4-(-3-hydroxyphenyl)piperidine, a compound known to have nonselective opioid antagonist activity. 56 The most active compound identifi ed was RTI 5989-29 ( Figure 1 ), which was found to have a K i of 7 nM. The compound was found to have antagonist activity at both the kappa and mu receptors ( Table 1 ) .
IN VIVO SCREENING OF MIXTURE-BASED LIBRARIES
Our laboratory has more than 15 years of experience in the synthesis and screening of mixture-based combinatorial libraries in target-based in vitro assays. It is now imperative to explore the enormous potential of the direct in vivo testing of the many mixture-based chemically diverse libraries as a superior approach to drug discovery. Our future studies will seek to demonstrate that the direct in vivo screening and deconvolution of mixture-based combinatorial libraries is a better approach to the identifi cation of fundamentally more " advanced " therapeutic candidates. This new approach should prove faster and cheaper than the typical target-based drug discovery process.
A series of preliminary experiments have been conducted as proof of concept studies to validate the use of mixture-based libraries reported to exhibit opioid activity in an in vivo model. In this study we compared the activity of mixtures of tetrapeptides each containing 125 000 tetrapeptides. These peptide mixtures were based on the known active dermorphin analog 2,6-dimethyltyrosine-DALDA ([Dmt]-DALDA = H-Dmt-D-Arg-Phe-Lys-NH 2 ). Dmt-DALDA was identifi ed through the outstanding classical synthetic medicinal chemistry effort by Schiller ' s group. 60 These compounds have high mu opioid receptor affi nity 60 , 61 with proven in vivo antinociceptive properties in mice. 62 The Dmt-tyrosine group of [Dmt]-DALDA has been shown to be an essential component, as demonstrated by both in vitro and in vivo data. We therefore synthesized a positively biased mixture of 125 000 tetrapeptide compounds in which Dmt-tyrosine was fi xed at the fi rst position (Dmt-XXX). This mixture was examined for its activity and compared with the antinociceptive effect of the known active individual Dmt-DALDA and 2 negatively biased tetrapeptide mixtures (F-XXX and k-XXX, which are 800 and 3580 times less active in vitro, respectively; Table 2 ).
To assess the antinociceptive effects of these mixtures, we used the mouse tail fl ick assay since it is well established, yields clear and reproducible end points, and can differentiate between mu and kappa activity. Dmt-XXX, at a dose of 100 mg/kg, was active and had duration of action comparable to the individual compound [Dmt]-DALDA at 10 mg/kg ( Figure 2 ) . This effect appears to be specifi c since F-XXX-NH 2 was inactive at comparable doses. It was also observed that Dmt-XXX was longer acting than morphine (ie, 5 hours vs 1 hour), a property already reported for [Dmt]-DALDA, 62 and was maintained for the mixtures containing Dmt on the N-terminal. As anticipated, the mixtures required greater absolute doses than the individual compounds.
After achieving these results, we performed a single iteration by synthesizing the anticipated next Dmt-r-XX mixture; the second position was defi ned with D-arginine, which is the amino acid found in DALDA. This iteration decreases the complexity of the mixtures from 125 000 compounds (OXXX) to 2500 compounds (OOXX). The antinociceptive effects of these mixtures were tested in the tail fl ick assay as before. As the tetrapeptide mixture becomes more defi ned, one would expect an increase in activity when testing at the same concentration. It is of note that when decreasing the mixture size from 125 000 for Dmt-XXX to 2500 for Dmtr-XX the increase in activity was modest (4-fold in vitro) while the decrease in mixture size was 50-fold. This discrepancy can be explained by several different mechanisms. Clearly, more than 1 substitution at the second position can be accepted and activity retained (lysine may be an acceptable replacement for arginine). Additionally, it is important to point out that we fi xed D-arginine at the second position simply as a test study to expand this proof of concept for the use of mixture-based combinatorial libraries directly in vivo. There is in fact no reason to assume that D-arginine is the most functionally useful amino acid at the second position, especially in vivo. At 5 hours postinjection at a dose of 25 mg/kg this peptide mixture of 2500 tetrapeptides was clearly more active than morphine ( Figure 2 ). Six others were tested in vivo (Y-XXX, F-XXX, p-XXX, K-XXX, k-XXX, and D-XXX, data not shown), and the activities of these mixtures in binding and cAMP assays are shown in Table 2 . This expected correlation between the in vitro and in vivo activities was found for all except k-XXX, which had signifi cant tail fl ick activity from 30 minutes all the way through the 5-hour cutoff point. Of clear signifi cance in this study was that k-XXX, while having very poor activity in vitro, was clearly active in the tail fl ick test. This may be due to several factors, including the interaction at an unknown nonopiate receptor, the inhibition or stimulation of an enzyme, or a translational factor or signaling event. This result illustrates perhaps the central most exciting aspect of the proposed studies, namely the direct in vivo identifi cation of mixtures that may be active as pain-modulating agents at sites other than the expected 3 opiate receptors. These preliminary results are encouraging, and testing will be continued to determine individual compounds.
CONCLUSIONS
A wide range of combinatorial libraries, from peptides to low-molecular-weight heterocyclic compounds, have been successfully screened in assays specifi c for the opioid receptors and have enabled the identifi cation of new ligands for these receptors. New opioid peptides found from combinatorial libraries range in length from tetramers to decamers. The compounds described in this review are the most active
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found and represent only a fraction of the number of individual peptides and nonpeptidic compounds synthesized and tested. All the peptides found have an amide at the carboxyl terminus, as all libraries screened were in this format. Some of the peptides resemble the classical opioids -they possess a tyrosine at position 1 and a tertiary amino group on the N terminus. The peptide YPWFPO-NH 2 is a hexapeptide analog of the recently described tetrapeptide endomorphin-1 (YPWF-NH 2 ), thought to be the endogenous ligand for the mu receptor. 63 The delta-selective hexapeptides identifi ed possess both Tyr 1 and Leu 5 but differ from each other and the enkephalins at the remaining positions. YHGWLV-NH 2 has a conservative replacement of Phe 4 by Trp 4 ; thus, it differs from the enkephalin mainly at the His 2 . It is assumed that Val 6 is redundant, although this has not yet been tested. The 2 remaining delta peptides have replacements at the fourth and fi fth positions (YGMHLV-NH 2 and YGFDLV-NH 2 ). Novel peptides identifi ed for the opioid receptors were found to contain basic residues (arginine and lysine), and many also contain tryptophan. Basic residues are found in position 1 in the acetalins and in the all D-amino acid peptide, Ac-rfwink-NH 2 . They are also found on the C-terminal residue in peptides selective for mu, delta, or kappa (WWPR-NH 2 , Wy(Nve)R-NH 2 , and f(D-nal)(Dnle)r-NH 2 , respectively). The highly active and receptorspecifi c tetrapeptide ligands have been fully developed and are now in phase I human trials.
It is still unclear what is required for a compound to bind to opioid receptors and what the effect of binding will be. It was assumed that compounds identifi ed from very large mixture-based libraries would in virtually all instances be identifi ed as antagonists since it was reasoned that there must be many more ways to block a binding interaction with one of many thousands of compounds than to bind and affect a secondary signaling event. Antagonists need only bind to a receptor in order to block another ligand from binding, whereas an agonist must not only bind but also induce a conformational change in the receptor in order to achieve signal transduction. Thus, the mu agonist activity of Ac-rfwink-NH 2 was unexpected. Furthermore, the acetalins (Ac-RFMWMK-NH 2 ), which have sequence similarities to Ac-rfwink-NH 2 although they are composed entirely of L-amino acids, were found to be antagonists. Certainly the identifi cation of the opioid peptide Acrfwink-NH 2 , which does not require a phenolic hydroxyl or a tertiary amino group to be an agonist, challenges the preconception that these pharmocophores are required for agonist activity. Since then we have found that greater than 80% of the new sequences identifi ed are agonists at the opioid receptors. Whether the high percentage of agonists found is due to a bias resulting from the specifi c radioligand used in the initial library screen has yet to be determined.
The high numbers of different compounds identifi ed raises the question of the plasticity of the opioid receptors. Why are new ligands of widely varying structures so readily identifi ed for the opioid receptors, particularly the mu receptor? This is not the case for other G-coupled receptors, even for the orphanin FQ/nociceptin receptor, at which few libraries are found to have activity. The plasticity of the mu receptor may account for the high numbers of novel agonists identifi ed. The data obtained from in vivo studies on these new opioid ligands should generate interesting insights into this question.
Finally, the use of mixture-based libraries for direct in vivo testing for the identifi cation of inherently more advanced " hits " was demonstrated here in a proof of concept illustration. This process, found to work well in preliminary studies with peptides and classic low molecular weight heterocyclic mixtures, will make the drug discovery process much faster than it has been with traditional target-based in vitro assays. Future studies will explore the enormous potential of the direct in vivo testing of the many mixture-based chemical of diverse libraries in an effort to reduce the time and resources required for drug discovery. This new approach is expected to lead to the identifi cation of novel pain-modulating agents for the 3 opiate receptors and the identifi cation of ligands to a variety of other orphan receptors that may play a role in pain regulation. 
